Satoshi Watanabe

31PUBLICATIONS
96CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMolecular targetsExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Oct 26, 2026
Effect of Intratumoral PD-L1 Expression on Treatment Efficacy of ALK Tyrosine Kinase Inhibitors for Advanced or Recurrent ALK-Positive Non-small Cell Lung Cancer.

|Oct 16, 2026
A Retrospective Study of the Efficacy and Safety of Chemoimmunotherapy in Elderly Patients with Extensive-Stage Small Cell Lung Cancer.

|Jun 19, 2026
Clinical Factors Associated With Non-Completion of Durvalumab Maintenance Therapy After Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.

|Jun 17, 2026
Sarcomatoid Transformation of Pulmonary Mucinous Adenocarcinoma as a Mechanism of Immunotherapy Resistance.

|Mar 05, 2026
Nintedanib enhances the antitumor efficacy of pd-1 blockade, potentially through inhibition of myeloid-derived suppressor cells and cancer-associated fibroblasts.

Ryo Suzuki, Satoshi Watanabe, Kunihiro Shono

|Feb 26, 2026
Is Plasma Total Antioxidant Capacity Elevated in Professional Soccer Athletes?: A Cross-Sectional Study.

Tomoharu Mochizuki, Takashi Ushiki, Hikaru Kanome

Pageof 6

Frequent Collaborators

7 joint publications

Toshiaki Kikuchi

5 joint publications

Akihiro Yoshimura

4 joint publications

Tadaaki Yamada

4 joint publications

Yasuhiro Goto